ADMA Biologics, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	114.5M	139.2M	134.2M	122.0M	114.8M	117.5M	119.8M	107.2M
Cost of Goods Sold	33.7M	50.3M	58.6M	54.8M	53.7M	54.2M	60.2M	49.7M
Gross Profit	80.8M	88.8M	75.6M	67.2M	61.1M	63.3M	59.7M	57.5M
R&D Expenses	2.6M	1.4M	1.5M	1.0M	826K	391K	412K	560K
Operating Expenses	30.4M	26.1M	24.6M	24.4M	26.2M	25.0M	20.0M	18.3M
Operating Income	50.3M	62.8M	51.0M	42.8M	34.9M	38.3M	39.6M	39.2M
Other Income / Gains	6.8M	-1.2M	-3.5M	-2.7M	-1.4M	-3.6M	-2.9M	-3.4M
Net Income	45.3M	49.4M	36.4M	34.2M	26.9M	111.9M	35.9M	32.1M
EPS (Diluted)	0.19	0.21	0.15	0.14	0.11	0.47	0.15	0.14
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.705	0.638	0.563	0.551	0.532	0.539	0.498	0.536
General And Administrative Expenses	0	0	0	0	0	0	0	0
Selling And Marketing Expenses	0	0	0	0	0	0	0	0
Selling General And Administrative Expenses	26.7M	23.5M	23.0M	22.2M	24.1M	23.3M	18.6M	16.6M
Other Expenses	1.1M	1.2M	38K	1.2M	1.3M	1.3M	1.0M	1.1M
Cost And Expenses	64.2M	76.4M	83.2M	79.2M	79.9M	79.2M	80.2M	68.0M
Interest Income	1.1M	487K	376K	400K	608K	598K	666K	449K
Interest Expense	2.1M	1.6M	1.7M	1.8M	2.0M	2.9M	3.5M	3.8M
Depreciation And Amortization	1.8M	2.0M	2.0M	2.1M	2.0M	1.9M	1.9M	2.0M
Ebitda	52.1M	65.3M	51.2M	44.0M	37.4M	39.5M	42.2M	41.7M
Ebitdaratio	0.455	0.469	0.382	0.361	0.326	0.336	0.352	0.389
Operating Income Ratio	0.439	0.451	0.38	0.351	0.304	0.326	0.331	0.366
Income Before Tax	57.1M	61.6M	47.5M	40.1M	33.5M	34.7M	36.7M	35.9M
Income Before Tax Ratio	0.499	0.443	0.354	0.329	0.291	0.295	0.307	0.334
Income Tax Expense	11.8M	12.2M	11.1M	5.9M	6.5M	-77.2M	840K	3.8M
Net Income Ratio	0.396	0.355	0.271	0.281	0.234	0.952	0.30	0.299
Epsdiluted	0.19	0.20	0.15	0.14	0.11	0.46	0.15	0.13
Weighted Average Shs Out	236.1M	238.0M	238.6M	241.5M	237.8M	236.4M	234.6M	232.4M
Weighted Average Shs Out Dil	240.0M	243.9M	244.7M	248.6M	244.7M	245.9M	244.8M	242.2M